Drug Shortage Report for ENGERIX B

Last updated on 2019-01-11
Report ID 6511
Drug Identification Number 01919431
Brand name ENGERIX B INJ SUS 20MCG/ML
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-04-06
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-01-11
Company comments Demand increase coupled with disruption of the manufacture of the drug. Most recent supply released December 19, 2018 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. Supply available for public programs.
Health Canada comments
Company contact information 1-800-387-7374